Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Richard Kuntz Insider Profile

4 Followers

Richard Kuntz, Director at INVE Technologies, holds 65.71K shares in INVE Technologies (Ticker: INVE), holds 24.21K shares in Diamedica Therapeutics (Ticker: DMAC), holds 74.94K shares in Medtronic (Ticker: MDT).

Richard Kuntz's Trading History

INVEINVE Technologies		Aug 03, 2026DirectorUninformative Buy―$178.08K
DMACDiamedica Therapeutics		Jan 02, 2024DirectorUninformative Buy40.00K$223.94K
MDTMedtronic		Nov 09, 2021SVP & Chief Medical & ScienceUninformative Sell25.70K$7.24M
ZIMVZimVie Inc		――――
RKLYQRockley Photonics Holdings		――――
See All Insider Trading from Today

You May Also Like

Meet our Smart Portfolio. See what top analysts say about your stocks.Get a breakdown of the different strategies based on detected insider trading activity.Find the best performing Analyst in each sector. Follow them so you never miss a recommendation.

Richard Kuntz insider profile FAQ

What is the percentage of profitable transactions made by Richard Kuntz?
The percentage of profitable transactions made by Richard Kuntz is 0%.
What is the average return per transaction made by Richard Kuntz?
The average return per transaction made by Richard Kuntz is -12.10%.
What stocks does Richard Kuntz hold?
Richard Kuntz holds: INVE, MDT, DMAC, RKLYQ, ZIMV stocks.
What was Richard Kuntz's most profitable transaction?
Richard Kuntz’s most profitable transaction was an Informative Sell of MDT stock on January 10, 2018. The return on the trade was -1.40%.
What is Richard Kuntz's role in INVE Technologies?
Richard Kuntz's role in INVE Technologies is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.